Refine
Year of publication
Document Type
- Doctoral Thesis (19)
- Article (1)
Has Fulltext
- yes (20)
Is part of the Bibliography
- no (20)
Keywords
- Streptococcus pneumoniae (20) (remove)
Institute
Publisher
- Karger (1)
Pneumokokken haben verschiedene Virulenzfaktoren, die nicht nur den Kolonisierungsprozess unterstützen, sondern auch das Vordringen des Pathogens in tiefere Gewebsschichten ermöglichen oder einen Schutz vor den Komponenten des Immunsystems vermitteln. Diese Virulenzfaktoren stehen im Mittelpunkt der Untersuchungen für die aktuelle Impfstoffentwicklung. Die genomische Analyse verschiedener Streptococcus pneumoniae Stämme identifizierte den Pneumococcal adherence and virulence factor B (PavB) als LPXTG-verankertes Oberflächenprotein. PavB enthält repetitive SSURE-Sequenzen (Streptococcal Surface Repeats), die mit humanem Fibronektin interagieren. Das Molekulargewicht des hochkonservierten Proteins wird von der Anzahl der SSURE-Domänen bestimmt und variiert zwischen den unterschiedlichen Pneumokokkenstämmen. In dieser Arbeit konnte gezeigt werden, dass PavB ein Adhäsin auf der Oberfläche von Pneumokokken darstellt und am Kolonisierungsprozess der Pneumokokken unter in vivo Bedingungen beteiligt ist. Mäuse, die intranasal mit pavB-Deletions-Mutanten infiziert wurden, überlebten signifikant länger als die mit den Wildtypbakterien infizierten Tiere. Der PavB-defiziente Stamm zeigte im Vergleich zum parentalen Wildtyp eine verringerte Kolonisierung des Nasopharynx sowie eine verzögerte Ausbreitung in die Lunge. Dies konnte in Echtzeit unter Verwendung von biolumineszierenden Pneumokokken gezeigt werden. In Koinfektionsexperimenten mit gleichen Infektionsdosen von Wildtyp-Pneumokokken und isogenen pavB-Mutanten war die Mutante in ihrer Fähigkeit, sich in den Organen der oberen und unteren Atemwege auszubreiten, eingeschränkt. Im Gegensatz dazu war die Pathogenese einer Meningitis nach intrazerebraler Injektion der Pneumokokken, sowie die Erkennung und Phagozytose durch phagozytierende Zellen des angeborenen Immunsystems, unabhängig von der Produktion des PavB Proteins. Die Immunogenität des Oberflächenproteins unter relevanten Bedingungen wurde durch den Nachweis von PavB-spezifischen Antikörpern in Patientenseren gezeigt. Auf eine Rolle des Oberflächenproteins PavB während der bakteriellen Adhäsion an eukaryotische Zellen deuteten die Infektionsexperimente mit humanen Epithelzelllinien. Es wurden verschiede His6-getaggte PavB-Derivate (SSURE2, SSURE2+3, SSURE1-5) für die weitere funktionelle Charakterisierung von PavB gereinigt und in Bindungsstudien eingesetzt. Die Funktion von PavB als Adhäsin konnte in Kompetitionsexperimenten unter Verwendung eines PavB-Derivats als Inhibitor bestätigt werden. Ebenso konnte die direkte Bindung des Proteins an eukaryotische Zellen nachgewiesen werden, wobei der eukaryotische Rezeptor noch nicht identifiziert wurde. In Protein-Protein-Interaktionsstudien wurden zusätzlich zu Fibronektin weitere humane Proteine des Plasmas und der extrazellulären Matrix (EZM), die im Laufe einer Infektion mit Pneumokokken einen Vorteil für das bakterielle Überleben im Wirt vermitteln könnten, als Bindungspartner für die drei gereinigten SSURE-Proteine identifiziert. Als neues Fibronektin-Bindungsprotein (FnBP) von S. pneumoniae diente PavB desweiteren für die Bestimmung der Bindungsregion von FnBPs von Pneumokokken im Fibronektinmolekül. Die Verwendung rekombinanter Fibronektinfragmente (His6-FnIII-Fragmente) ermöglichte den Nachweis der Beteiligung der Typ III-Domänen des C-terminalen Bereichs von Plasmafibronektin an der Interaktion zwischen PavB-Derivaten und Fibronektin. Die Bedeutung von Plasmafibronektin (pFn) für die Pathogenese einer Pneumonie wurde in einem induzierbaren knockout-Mausmodell für Plasmafibronektin untersucht. Nach intranasaler Infektion der Mäuse mit S. pneumoniae hatte der Verlust des Plasmaproteins unter den verwendeten Bedingungen keine signifikante Auswirkung auf die Entstehung einer Lungenentzündung oder die Überlebensaussicht der pFn-knockout-Mäuse. Unter in vitro Bedingungen bewirkte die Bindung von pFn an phagozytierende Zellen eine erhöhte Bindung der Pneumokokken an die Phagozyten. Dagegen beeinflusste die Rekrutierung von pFn an die Pneumokokkenoberfläche nicht die Phagozytose. Bisher konnte nicht eindeutig geklärt werden, welche Funktion Fibronektin während der Infektion mit Pneumokokken ausübt. Neben seinen multifunktionellen Bindungseigenschaften stellt das hochkonservierte Protein PavB einen interessanten Bestandteil für ein neues, Protein-basiertes Pneumokokkenvakzin dar.
Als Mitglieder der Ordnung Lactobacillales ist das Hauptkatabolit der Pneumokokken sowohl unter aerober wie auch microaerophiler Atmosphäre Lactat. Des Weiteren synthetisiert S. pneumoniae eine große Bandbreite an ABC-Transportersystemen, die an der Assimilation und an dem Stoffwechsel von Kohlenhydraten, löslichen Verbindungen und Aminosäuren beteiligt sind. In dieser Arbeit wurde der Kohlenstoffmetabolismus mittels 13C-Isotopologen Verteilung nach Wachstum der Pneumokokkenkultur in chemisch definiertem Medium (CDM) mit [U-13C6]Glucose, [1,2-13C2]Glucose oder [U-13C2]Glycin analysiert. GC/MS-Analysen zeigten ein Muster an schwer-markierten und unmarkierten Kohlenstoffatomen in den Aminosäuren. Die Ergebnisse ließen den Schluss zu, dass Pneumokokken sowohl einzelne Aminosäuren aufnehmen, wie auch über klassische oder nicht-klassische Biosynthesewege de novo synthetisieren können. His, Glu, Ile, Leu, Val, Pro und Gly blieben im Isotopolog Profiling unmarkiert, was ein Hinweis auf das Fehlen von Biosynthesewegen oder ihrer Regulation unter bestimmten Umweltbedingungen sein könnte. Obwohl die genetische Information für die Biosynthese der essentiellen verzweigtkettigen Aminosäuren (BAA; Ile, Leu und Val) in S. pneumoniae vorhanden ist, ergaben die 13C-Markierungsversuche keine de novo Synthese. Jedoch konnte durch Langzeit-1H-NMR (LT-NMR) Analysen eine aktive Aufnahme dieser Aminosäuren nachgewiesen werden. Darüber hinaus wird Aspartat nicht über den allgemeinen Stoffwechselweg mit Pyruvat und Acetyl-CoA synthetisiert. Die Aspartat-Synthese erfolgt im ersten Schritt durch die Umwandlung von Phosphoenolpyruvat (PEP) und CO2 zu Oxalacetat. Im zweiten Schritt wird Oxalacetat dann in Aspartat mit der Nebenreaktion Glutamat zu alpha-Ketoglutarat durch die Aspartat-Transaminase metabolisiert. GC/MS Analysen ergaben weiterhin, dass komplett markierte aromatische Aminosäuren aus Erythrose-4-Phosphat und zwei Molekülen PEP über das Intermediat Chorismat synthetisiert wurden. Es zeigte sich außerdem, dass [M+1] markiertes Serin durch die Hydroxymethylierung von unmarkiertem Glycin über 5,10-Methylentetrahydrofolat als Teil des C1-Pools hergestellt wurde. Weiterhin wurden In LT-NMR-Untersuchungen Konzentrationsänderungen der extrazellulären Metabolite quantifizert. Die homofermentative Milchsäuregärung konnte in Pneumokokken durch einen extrazellulären Anstieg der Lactatkonzentration nachgewiesen werden. Als essentielle Kandidaten wurden Glutamin und Uracil identifiziert, die das Pneumokokkenwachstum bei Mangel einschränken. Diese Ergebnisse zeigen die Vielzahl von Aminosäuren-Synthesewegen in Pneumkokken und die notwendige Rolle der Transportersysteme in Pneumokokken für die bakterielle Fitness und für die Adaption an verschiedene Wirtsnischen. Sechs mögliche Glutamin-Aufnahmesysteme konnten durch Genomanalysen von Streptococcus pneumoniae Stämmen identifiziert werden. Die Reverse Transkriptions-PCR haben gezeigt, dass die sechs gln-Operons unter in vitro Bedingungen exprimiert werden. Vier der gln-Gencluster bestehen aus den Genen glnQPH, während in zwei Regionen das Gen glnH, welches für eine lösliche Glutamin-Bindungsdomäne kodiert, fehlt. In dieser Arbeit wurde der Einfluss zwei dieser Glutamin-ABC-Transporter, mit den Operons glnQPH0411/0412 und glnQPH1098/1099, in S. pneumoniae D39 auf Virulenz und Phagozytose untersucht. Die zwei charakterisierten Transportersysteme bestehen jeweils aus der ATPase GlnQ und einem translatorischem Fusionsprotein aus der Permease GlnP und dem Bindungsprotein GlnH. Für die Untersuchungen wurden diese beiden Transporter mittels Insertations-Deletions-Mutagenese inaktiviert. CD-1 Mäuse, die intranasal mit biolumineszierenden D39delgln0411/0412 infiziert wurden, zeigten in Echtzeit eine signifikant erhöhte Überlebenszeit und eine Attenuierung bei der Ausprägung einer Pneumonie im Vergleich zu biolumineszierenden Wildtyp D39 Pneumokokken. Im murinen Sepsismodell mit der D39delgln0411/0412-Mutante zeigte sich eine gemäßigte, aber signifikante Abschwächung der Pathogenese. Im Gegensatz dazu war die D39delgln1098/1099 Mutante sowohl im murinen Pneumonie- wie auch Sepsismodell massiv attenuiert. Es war eine 100- bis 10000- fach höhere Infektionsdosis erforderlich, um mit der D39delgln1098/1099-Mutante eine vergleichbare Pathogenese der Pneumonie oder Sepsis wie beim Wildtypstamm D39 hervorzurufen. Im experimentellen Meningitismodell zeigten sich bei der D39delgln1098/1099-Mutante eine erniedrigte Anzahl an Leukozyten im Liquor und ein reduzierter Bakterientiter im Blut im Vergleich zu D39 und D39delgln0411/0412. Auch die Phagozytose-Experimente bestätigten eine signifikante verminderte Überlebensrate der beiden gln-Mutanten im Vergleich zum Wildtyp S. pneumoniae D39, was auf den Einfluss der bakteriellen Fitness auf den Schutz gegen oxidativen Stress hinweist. Diese Ergebnisse demonstrierten, dass beide Glutamin-Aufnahmesysteme für die vollständige Virulenz der Pneumokokken essentiell sind, aber verschiedene Auswirkungen auf die Pathogenese der Bakterien unter in vivo Bedingungen haben. Das Zelloberflächenprotein PavA der Pneumokokken ist ein Virulenzfaktor, der für invasive Erkrankungen wichtig ist. In dieser Arbeit wurde gezeigt, dass PavA essentiell für die in vivo Besiedlung von Streptococcus pneumoniae D39 in den oberen Atemwegen von Mäusen ist. In dem murinen Pneumoniemodell wurden pavA-Mutanten nicht aus den infizierten Mauslungen eliminiert, sondern persistierten und lösten somit eine chronische Infektion aus, während Wildtyp-Pneumokokken systemische Erkrankungen verursachten. PavA-defiziente Pneumokokken konnten unter experimentellen Bedingungen nicht aus der Lunge in die Blutbahn streuen. Diese Ergebnisse ließen den Schluss zu, dass PavA an der erfolgreichen Kolonisation der Schleimhautoberflächen und an der Translokation der Pneumokokken durch Wirtsbarrieren beteiligt ist.
Streptococcus pneumoniae, more commonly known as the pneumococcus, is a Gram-positive bacterium colonizing the human upper respiratory tract as a commensal. However, these apparently harmless bacteria have also a high virulence potential and are known as the etiologic agent of respiratory and life-threatening invasive diseases. Dissemination of pneumococci from the nasopharynx into the lungs or bloodstream leads to community-acquired pneumonia, septicaemia and meningitis. Pneumococcal diseases are treated with antibiotics and prevented with polysaccharide-based vaccines. However, due to the increase of antibiotic resistance and limitations of the current vaccines, the burden of diseases remains high. Interactions of pneumococci with soluble host proteins or cellular receptors are crucial for adherence, colonization, transmigration of host barriers and immune evasion. The pneumococcal surface-exposed proteins are the main players involved in this host-pathogen interaction. Therefore, combating pneumococcal transmission and infections has emphasized the need for a new generation of immunogenic and highly protective pneumococcal vaccines, based on surface-exposed adhesins virtually expressed by all pneumococcal strains and serotypes. The genomic analysis of S. pneumoniae strains helped to identify pneumococcal virulence factors such as pili, PsrP and PavB, which have been demonstrated to interact with human proteins playing an important role during the pathogenic process of pneumococci, and are currently considered as new potential vaccine candidates against S. pneumoniae. A subclass of pneumococcal strains produces pili that are encoded by the pathogenicity islet pilus islet-1 (rlrA islet) and/or the pilus islet-2. Both types of pili are implicated in bacterial adherence to host cells. A further pathogenicity islet encoded protein is PsrP. The presence of the psrP-secY2A2 islet correlated positively with the ability of pneumococci to cause invasive pneumococcal diseases. Recent studies indicated that PsrP is a protective adhesin interacting with keratin 10 on lung epithelial cells. In this study, the genomic loci of the pneumococcal virulence factors pili, PsrP and PavB were molecularly analyzed and used as molecular markers for molecular epidemiology studies of S. pneumoniae. The genotyping results obtained here showed the impact of the PCV7 immunization of children, started in July 2006, on the distribution of these pneumococcal virulence factors among clinical isolates in Germany. These findings gave more insights into the role of pili, PsrP and PavB in pneumococcal pathogenesis and may strongly support the idea of including these pneumococcal constituents in a broad coverage protein-based vaccine against pneumococcal infections produced by invasive serotypes in the future. The mature PavB protein contains a variable number of repetitive sequences referred to as the Streptococcal Surface Repeats (SSURE). PavB has been demonstrated to interact with fibronectin and plasminogen in a dose-dependent manner and it was identified as a surface-exposed adhesin with immunogenic properties, which contributes to pneumococcal colonization and respiratory airways infections. The complete molecular analysis performed here for PavB, allowed to know more accurately its structure and to estimate the real number of SSURE units in different pneumococcal strains. With these findings, a new primary sequence-based structural model was constructed for the PavB protein and its SSURE domain, and, at least for TIGR4, the complete pavB gene and PavB protein sequences with five SSURE units was reported in the GenBank database of the NCBI website. Due to its immediate neighborhood on the pneumococcal genome with the tcs08 genes, PavB is likely linked with this pneumococcal TCS. Here, a significant reduction of the PavB protein expression was observed in delta-tcs08-mutant strains, which may strongly suggest that the TCS08 does play a role in pneumococcal virulence and metabolisme, as further observed in growth behaviour experiments carried out with the TCS08-deficient mutants, cultured in chemically defined medium. Despite several studies suggest that the molecular mechanism underlying the bacterial signal transduction is very sophisticated, the majority of reports in prokaryotic TCS, including those for S. pneumoniae, are still focused in single cognate pairs. The pneumococcal genome encodes 14 TCSs and an orphan response regulator. It is obvious that TCS pathways are often arranged into complex circuits with extensive cross-regulation at a variety of levels, thereby endowing cells with the ability to perform sophisticated information processing tasks. This study established also the experimental and molecular bases for the construction of a comprehensive genome-wide interaction map of the complex TCS pathways for its application in the gene regulation of pneumococcal virulence factors.
Streptococcus pneumoniae (pneumococci) are Gram-positive cocci and commensals of the human upper respiratory tract. Pneumococcal pathogenesis requires adherence to host cells and dissemination through cellular barriers and to evade host defense mechanisms. The Pneumococcal surface protein C (PspC) is an important virulence factor which has a crucial role in pneumococcal adhesion to host cells and immune evasion by manipulating the host complement system. To elucidate the pneumococcal adherence and uptake mechanism via factor H glycosaminoglycans (dermatan sulfate and heparin) were employed as competitive inhibitors in infection experiments with epithelial cells or human polymorphonuclear leukocytes (PMNs). Glycosaminoglycans significantly inhibited the FH mediated pneumococcal adherence and subsequent invasion to host epithelial cells. Furthermore, the short consensus repeats of FH which promotes the adhesion of pneumococci to host cells were identified by blocking experiments with domain mapped antibodies for specific regions of FH. Moreover, this study indicates that FH acts as adhesion molecule via cellular receptors recognized as integrin CR3 on human PMNs. Binding of Factor H loaded pneumococci to integrins CR3 was assessed by flow cytometry. Pneumococci coated with Factor H showed a significantly increased association with PMNs. This interaction was blocked by anti-CR3 antibodies and Pra1. This project further aims to study mechanisms of pneumococcal endocytosis by host cells, their intracellular fate, and the pathogen induced host cell signal transduction cascades including the calcium signaling upon pneumococcal infection of host cells via the PspC-hpIgR interaction. To assess now the role of protein tyrosine kinases (PTKs) during pneumococcal infection via PspC, cell culture infections were performed in presence of pharmacological inhibitors of PTKs and MAPKs or by employing genetic interference techniques. Blocking the function of Src or ER1/2 and JNK and genetic-knock down of Src and FAK reduced significantly internalization of pneumococci. These data indicated the importance of a coordinated signaling between Src PTKs, ERK1/2, and JNK during PspC-pIgR-mediated uptake of pneumococci by host epithelial cells. The impact of host cells intracellular calcium concentrations on pneumococcal PspC-hpIgR mediated internalization was studied. Intracellular calcium measurement of epithelial cells performed in the presence of pneumococci suggested a calcium influx in host epithelial cells and importantly this calcium influx was PspC- hpIgR specific as pspC-deficient pneumococci were unable to mediate calcium mobilization in host cells. The increase in intracellular calcium [Ca2+]i was dependent on phospholipase C as pretreatment of cells with a phospholipase C-specific inhibitor abolished the increase in [Ca2+]i. Furthermore, role of host intracellular calcium concentrations during pneumococcal internalization was demonstrated by employing specific pharmacological inhibitors and calcium chelators in epithelial cell culture infection assays. The results revealed that elevated host cells calcium concentrations diminished pneumococcal internalization while lower calcium concentration in host epithelial cells promoted pneumococcal uptake. This study further demonstrates that dynamin, clathrin and caveolin play a key role during pneumococcal endocytosis into host cells via PspC-hpIgR. The use of specific pharmacological inhibitors or genetic interference approaches against dynamin, clathrin and caveolin in epithelial cell culture infection assays significantly blocked pneumococcal uptake. Furthermore, confocal microscopy revealed that pneumococci co-localize with clathrin. At later stages of the infection the pathogen is sorted to early, late and recycling endosomes as indicated by co-localization of pneumococci with endosomal markers such as Rab5, Rab4, Rab 7, and Lamp1. In order to get further insights into PspC-hpIgR mediated uptake mechanisms, a chimeric PspC was constructed and expressed heterologously on the surface of Lactococcus lactis. Immunofluorescence staining, immunoblot and flow cytometric analysis of L. lactis confirmed the expression of PspC on the bacterial surface. Moreover the ability of recombinant lactococci expressing PspC to adhere to and to invade pIgR-expressing epithelial cells confirmed the functional activity of PspC when exposed on the lactococcal surface. PspC expressing lactococci confirmed the specificity of PspC-hpIgR mediated endocytosis in host epithelial cells as PspC deficient lactococci were not taken up by these host cells. Confocal microscopic analysis demonstrated that only PspC expressing lactococci were sorted to early, late and recycling endosomes, similar to the intracellular fate of S. pneumoniae.
Streptococcus pneumoniae (Pneumokokken) sind Gram-positive und Katalase-negative humanspezifische Kommensalen der oberen und unteren Atemwege. Diese Bakterien sind andererseits auch als schwere Krankheitserreger bekannt und verursachen bei verschiedenen Bevölkerungsgruppen, wie beispielsweise Kindern, Älteren und immungeschwächten Personen sowohl Atemwegs- als auch lebensbedrohliche invasive Erkrankungen wie eine ambulant erworbene Pneumonie, Meningitis und Sepsis. Pneumokokken haben aufgrund ihrer Besiedelung des Respirationstraktes effiziente Mechanismen entwickelt, um in einer sauerstoffreichen Nische überleben zu können. Dabei richten sich die Mechanismen vor allem gegen reaktive Sauerstoffspezies (Reactive Oxygen Spezies, ROS), die einerseits als Abwehrfunktion des Wirts (oxidative burst) vom angeborenen Immunsystem und andererseits von den Pneumokokken selbst produziert werden, um als chemische Waffe zur Bekämpfung bakterieller Konkurrenten in ihrem Habitat eingesetzt zu werden. In der vorliegenden Arbeit wurde ein hochkonserviertes Zwei-Operon-System, das für die extrazelluläre oxidative Stress-Resistenz in S. pneumoniae verantwortlich ist, identifiziert und auf pathophysiologischer sowie struktureller Ebene charakterisiert. Dieses komplexe System besteht aus zwei integralen Cytochrom C-ähnlichen Membranproteinen (CcdA1 und CcdA2), zwei Thioredoxin-ähnlichen Lipoproteinen (Etrx1 und Etrx2) und einer Methioninsulfoxid-Reduktase AB2 (MsrAB2). Die Etrx-Proteine werden zwar in zwei räumlich voneinander getrennten Operonen kodiert, sind aber funktionell miteinander verbunden. Der Einfluss des Systems auf die Pathogenese der Pneumokokken wurde in Maus-Virulenz-Studien und Untersuchungen der Phagozytose unter Verwendung von isogenen Mutanten gezeigt. Sowohl in den in vivo als auch den in vitro Experimenten konnte gezeigt werden, dass der Verlust der Funktion beider Etrx-Proteine beziehungsweise der Methioninsulfoxid-Reduktase MsrAB2 die Virulenz der Pneumokokken stark reduziert. Hieraus resultierte eine erheblich verringerte Letalität des Wirts, eine beschleunigte bakterielle Aufnahme durch die Makrophagen sowie ein schnelleres Abtöten der Pneumokokken durch eine oxidative Schädigung von Oberflächen-lokalisierten Proteinen mittels Wasserstoffperoxid. Die Ergebnisse deuten darauf hin, dass Etrx2 die Abwesenheit von Etrx1 und umgekehrt Etrx1 das Defizit von Etrx2 kompensieren kann. Durch Strukturaufklärung der beiden Thioredoxin-ähnlichen Proteine Etrx1 und Etrx2 sowie der Modellierung der beteiligten Komponenten CcdA und MsrAB2 konnte die Rolle jedes einzelnen Proteins dieses Systems (CcdA-Etrx-MsrAB2-System) bei der Reparatur beschädigter Oberflächen-lokalisierter Proteine in einem Modell dargestellt werden. Das postulierte Modell konnte über in vivo und in vitro Untersuchungen des Elektronentransfers innerhalb dieses Systems bestätigt werden. Mit der Bestimmung der Standardredoxpotentiale der rekombinanten Proteine Etrx1, Etrx2 und der Einzeldomänen MsrA2 und MsrB2 konnte in vitro gezeigt werden, dass der Elektronenfluss in Richtung von Etrx1 und Etrx2 zu MsrAB2 erfolgen muss. Die direkte Elektronenübertragung zwischen diesen Proteinen konnte in kinetischen Experimenten gezeigt werden. Die Messungen ergaben, dass Etrx1 bevorzugt mit der MsrA2-Untereinheit interagiert beziehungsweise Etrx2 sowohl mit der MsrA2-Untereinheit als auch mit der MsrB2-Untereinheit in Wechselwirkung treten kann. Der in vivo Redoxzustand von MsrAB2 wurde unter Verwendung der nicht-reduzierenden/reduzierenden „2D-Diagonal“-SDS-PAGE in den isogenen ccdA- und etrx-Mutanten bestimmt. Hierbei konnte ein Unterschied im Redoxzustand von MsrAB2 in den isogenen Einzelmutanten und Doppelmutanten von ccdA und etrx beobachtet werden. Während in den Einzelmutanten der Elektronenfluss innerhalb des CcdA-Etrx-MsrAB2-Systems unverändert war, zeigte sich in den Doppelmutanten ccdA1/ccdA2 und etrx1/etrx2 eine deutliche Beeinträchtigung der Elektronenübertragung auf MsrAB2, welche sich in der Zunahme der oxidierten Form von MsrAB2 deutlich machte. Somit konnte der Elektronenfluss von sowohl von CcdA1 über Etrx1 zu MsrAB2 als auch von CcdA2 über Etrx2 zu MsrAB2 in vivo betätigt werden. In Anbetracht der Ergebnisse dieser Arbeit könnte das hochkonservierte CcdA-Etrx-MsrAB2-System der extrazellulären oxidativen Stress-Resistenz von S. pneumoniae zur Entwicklung proteinbasierter Pneumokokken-Impfstoffe und zum Angriffspunkt für Behandlungen gegen diese wichtigen humanpathogenen Erreger beitragen.
Streptococcus pneumoniae (the pneumococcus) is a harmless resident of the human nasopharyngeal cavity, and, in general, every individual is likely to be colonized asymptomatically at least once during life. However, under certain conditions, the bacterium can spread to other tissues and organs causing local, non-invasive infections but also lifethreatening, invasive diseases. Pneumococcal carriage and infection is a highly regulated interplay between pathogen- and host-specific factors and the intimate contact of S. pneumoniae with the surface of the nasopharynx is the crucial step in pneumococcal pathogenesis. Pneumococcal adherence to the respiratory epithelium is mediated by surface-exposed adhesins. These adhesins engage host cell receptors either directly or indirectly by recognizing glycoproteins of the extracellular matrix (ECM) including structural components, such as collagens, laminins, and fibronectins, as well as plasma-derived ECM modulators, like vitronectin and Factor H. Pneumococcal surface protein C (PspC) is a surface-exposed protein and important virulence factor of S. pneumoniae. The multifunctional PspC protein promotes pneumococcal adherence to host cells by interacting with the secretory component of the human polymeric Immunoglobulin receptor of respiratory cells. In addition, PspC facilitates pneumococcal immune evasion by recruiting the complement inhibitor proteins C4b-binding protein (C4BP) and Factor H. Moreover, Factor H bound to the pneumococcal surface promotes bacterial adhesion to human epithelial and endothelial cells. S. pneumoniae also interacts with the human glycoprotein vitronectin. In plasma, monomeric vitronectin regulates thrombosis, fibrinolysis and the terminal complement cascade, while it additionally mediates cell-matrix interactions, cell adhesion and migration in the ECM. It was shown that multimeric, ECM-associated vitronectin facilitates pneumococcal adherence to respiratory epithelial cells. In addition, the interaction of pneumococci with vitronectin promotes their uptake by mucosal epithelial cells via the engagement of the integrin αvβ3 receptor and activation of intracellular signaling pathways culminating in cytoskeletal rearrangements. This study aims to identify and characterize the surface-exposed protein(s) that mediate binding of pneumococci to vitronectin and to elucidate the impact of vitronectin on pneumococcal pathogenesis beyond its function as molecular bridge between pneumococcus and host. Flow cytometric, immunosorbent and surface plasmon resonance experiments revealed that PspC is a vitronectin-binding protein of S. pneumoniae. The specificity of the interaction with vitronectin was confirmed using recombinant PspC proteins and Lactococcus lactis heterologously expressing PspC on their surface. Factor H did not hinder vitronectinbinding to PspC indicating that vitronectin recognizes the central part of PspC. Secretory IgA inhibited but not completely prevented vitronectin-binding to PspC, strongly suggesting that vitronectin binds near, but not directly to, the SC-binding region within the R domain(s) of PspC. In addition, PspC proteins comprising two R domains bound with higher affinity to vitronectin than PspC containing only one R domain, indicating that two interconnected R domains are required for efficient vitronectin-binding. Despite the sequential and structural differences to classical PspC, the PspC-like protein Hic specifically interacted with vitronectin with similar affinity than PspC containing two linked R domains. Binding studies confirmed that Factor H interacts with the very N-terminal region of Hic showing high sequence homology to classical PspC proteins, while vitronectin recognizes an adjacent region in the N-terminal region of Hic. The studied PspC proteins bound to both soluble and immobilized vitronectin, and the C-terminal heparin-binding domain (HBD3) was identified as PspC-binding motif in soluble vitronectin. However, in its immobilized form, vitronectin likely exposes additional binding sites for PspC since a region N-terminally to the identified HBD3 conferred binding of PspC. Vitronectin inhibits the terminal complement pathway, thereby preventing proinflammatory immune reactions and tissue damage. In general, pneumococci are protected from opsonization and MAC-dependent lysis by their capsule. However, pneumococci in close contact to human cells can become susceptible to complement attack due to reduced amounts of capsule. In addition, they can be severely affected by TCC-induced inflammatory responses. Vitronectin bound to PspC significantly inhibited the formation of terminal complement complexes. Thus, the interaction of PspC with vitronectin might aid in immune evasion of S. pneumoniae by inhibiting complement-mediated lysis and/or suppressing proinflammatory events. In conclusion, the results revealed the multifunctional PspC and Hic as vitronectin-binding proteins and proposed a novel role for the specific interaction of S. pneumoniae with vitronectin in regulating the complement cascade, beside its function as molecular bridge to the respiratory epithelium.
The influence of regulatory proteins on the physiology and virulence of Streptococcus pneumoniae
(2015)
In conclusion, this work identifies the regulator ArgR2 as activator of the S. pneumoniae TIGR4 arginine deiminase system and arginine-ornithine transporter ArcD, which is needed for uptake of the essential amino acid arginine. Although ArgR2 activates ArcD expression and uptake of arginine is required to maintain pneumococcal fitness, the deficiency of ArgR2 increases TIGR4 virulence under in vivo conditions, suggesting that other factors regulated by ArgR2 counterbalance the reduced uptake of arginine by ArcD. Thus this works illustrates that the physiological homeostasis of pneumococci is complex and that ArgR2 plays a key role in maintaining bacterial fitness. Moreover, Rex was identified as a regulator of housekeeping genes including genes encoding glycolytic enzymes. In vitro studies and gene expression analyses suggested that the regulator Rex does not have an influence on the physiology of S. pneumoniae. However, a co-infection experiment demonstrated that Rex is involved in maintaining pneumococcal fitness and robustness under in vivo conditions.
Posttranslationale Proteinmodifikationen beeinflussen Proteinaktivitäten und Signalwege innerhalb einer Zelle und haben somit vielfältige Auswirkungen auf den Stoffwechsel von Bakterien. Um die genauen Mechanismen besser verstehen zu können, wurde in dieser Arbeit das Phosphoproteom von Streptococcus pneumoniae D39 untersucht. Der Schwerpunkt lag dabei in der Entwicklung besserer Auswertestrategien und der damit einhergehenden verbesserten Identifizierung von Phosphoproteinen. Um dies zu bewerkstelligen, wurden die Proteinextrakte durch gelfreie und gelbasierte Methoden aufgetrennt. Die Auswertung der Experimente erfolgte zunächst durch klassische Proteinidentifizierung mit Hilfe von Proteindatenbanken. Zusätzlich wurden Spektrenbibliotheken von S. pneumoniae D39 aufgebaut und diese für eine bessere Proteinidentifizierung sowie Phosphoproteinidentifizierung genutzt. Anschließend wurden zur Quantifizierung des Phosphoproteoms dieses Pathogens verschiedene Quantifizierungsmethoden getestet und modifiziert. Hierbei wurde zum einen das Phosphoproteom einer Kinasedeletionsmutante von S. pneumoniae D39 über die Spotintensitäten von 2D Gelen mit dem Wildtyp verglichen. Zusätzlich wurden die Auswirkungen dieser Kinase auf das globale S. pneumoniae D39 Proteom mittels SILAC sowie der neu erstellten Spektrenbibliothek aufgezeigt. Eine weitere etablierte Quantifizierungsmethode für Phosphoproteine in der Arbeit war die Kombination von metabolischer Markierung und 2D Gelen. Die Veränderung des Phosphoproteoms wurde an dem industriell bedeutsamen Bakterium Bacillus pumilus anhand von oxidativem Stress aufgezeigt.
Streptococcus pneumoniae (pneumococci) and Staphylococcus aureus (S. aureus) are human-specific commensals of the upper respiratory tract. Every individual is asymptomatically colonized with both bacteria at least once in their life-time. The opportunistic pathogens can affect further organs and invade into deeper tissue. The occupation of normally sterile niches of the human body with the bacteria can lead to local infections such as sinusitis, otitis media and abscesses, or to life-threatening diseases like pneumonia, meningitis or sepsis. A strong interaction between the bacterium and the respiratory epithelial cells is a prerequisite for a successful colonization. This interaction is ensured by bacterial surface proteins, so called adhesins. The binding of the adhesins to the epithelial lineage occurs predominantly indirectly via components of the extracellular matrix (ECM), but also directly to cellular receptors. Pneumococci and S. aureus bind to various ECM glycoproteins, amongst others: fibronectin, fibrinogen, vitronectin, and collagen. Also binding of both pathogens to human thrombospondin-1 has been described. Thrombospondin-1 is mainly stored in the α-granula of thrombocytes (platelets) and released into the circulation upon activation. However, thrombospondin-1 is also produced and secreted by other cell types like endothelial cells, macrophages, and fibroblasts, which gets subsequently incorporated as component into the ECM. So far, no thrombosponin-1-binding adhesins of pneumococci were identified. PspC, Hic, and PavB are important surface-localized virulence factors, which were shown to interact with human ECM and plasma proteins. PspC and Hic bind to vitronectin and factor H, which inhibits the complement cascade of the human immune system. PavB interacts with fibronectin and plasminogen, and a pavB-deficient mutant of S. pneumoniae showed diminished capacity in colonization in a mouse model. Among the surface proteins of S. aureus, only Eap was identified as thrombospondin-1-binding adhesin. Beyond colonization, pneumococci and S. aureus can enter the blood circulation, interact with platelets, and cause their activation. The aggregation of platelets, especially initiated by S. aureus, plays an important role in the clinic, because most of the septic patients develop thrombocytopenia. Surface localized factors of
S. pneumoniae triggering platelet activation are unknown to date. In contrast, few proteins of S. aureus with potential to activate platelets, including Eap, were identified previously.
This study identified the surface proteins PavB, PspC, and Hic of S. pneumoniae as specific ligands of the human thrombospondin-1. Flow cytometric, surface plasmon resonance spectroscopic and immunological analyses revealed interactions between the pneumococcal proteins and soluble as well as immobilized thrombospondin-1. The use of specific pneumococcal deletion mutants verified the importance of the three virulence factors as binding partners of soluble thrombospondin-1. The results suggest that pneumococci are capable of acquiring soluble thrombospondin-1 from blood as well as utilizing immobilized glycoprotein of the ECM as substrate for adhesion. Furthermore, the thrombospondin-1-binding domain within the pneumococcal proteins was analyzed by use of recombinant fragments of PavB, PspC, and Hic. The binding capacity of thrombospondin-1 increased proportionally with the amount of repetitive sequences in PavB and PspC, and the length of the α-helical region within the Hic molecule. The binding behavior of thrombospondin-1 towards PavB and PspC is comparable with that of the ECM proteins vitronectin and fibronectin, but is unique towards Hic.
The localization of the binding domain of the adhesins within the thrompospondin-1 molecule occurred via use of glycosaminoglycans as competitive inhibitors for the interaction. The results suggest that the pneumococcal proteins Hic and PspC target the identical binding region within thrombospondin-1, which differs from the binding domain for PavB. However, all three virulence factors seem to bind in the N-terminal part of thrombospondin-1.
Two-dimensional gel electrophoresis, thrombospondin-1 overlay assay and subsequent mass spectrometric analysis identified AtlA of S. aureus as a surface localized interaction partner of human thrombospondin-1. Moreover, a vitronectin binding activity for AtlA was determined. Immunological and surface plasmon resonance binding studies with recombinant AtlA fragments revealed that interactions with both matrix proteins is mediated via the C-terminal located repeats R1R2 of the AtlA amidase domain. Binding of thrombospondin-1 and vitronectin occurred not simultaneously, due to a competitive inhibition.
The second part of the study focused on the activation of human platelets by recombinant pneumococcal and staphylococcal proteins. In total, 28 proteins of S. pneumoniae and 52 proteins of S. aureus were incubated with human platelets. The activation of the cells was detected by flow cytometry using the activation markers P-selectin and the dimerization of the integrin αIIbβIII. The proteins CbpL, PsaA, PavA, and SP_0899 of S. pneumoniae induced platelet activation, however, the detailed mechanism has to be deciphered in further studies. Furthermore, the secreted proteins CHIPS, FLIPr, and AtlA of S. aureus were discovered as inductors for the activation of platelets. In addition, the domains of AtlA and Eap, crucial for platelet activation, were narrowed down. Interestingly, CHIPS, FLIPr, and Eap were described as inhibitors of neutrophil recruitment. Platelets are recently recognized as immune cells, due to the expression of immune receptors. The data obtained in this study highlight a comprehensive spectrum of effects of the S. aureus proteins towards different type of immune cells. Besides the activation of platelets in suspension buffer and plasma, the aggregation of platelets in whole blood was triggered by the proteins CHIPS, AtlA, and Eap. These results suggest a contribution of the proteins during the S. aureus-induced infectious endocarditis. Secretion of the platelet activating virulence factors, which were identified within this study, might represent a pathogenic strategy during S. aureus infection in which a direct contact between S. aureus and platelets is not required or even avoided.
In conclusion, PavB, PspC, and Hic of S. pneumoniae and AtlA of S. aureus were identified as interaction partners of human thrombospondin-1. Furthermore, CHIPS, FLIPr, AtlA, and Eap were characterized as platelet activators. This study provides candidates for the development of protein-based vaccines, to prevent bacterial colonization and to neutralize secreted pathogenic factors.
Streptococcus pneumoniae is a commensal of the human upper respiratory tract and
the etiological agent of several life-threatening diseases. This pathogen is the model bacterium
for natural competence. Furthermore, the pneumococci played an important role in the
identification of DNA as the main molecule involved in bacterial transformation. As a result,
studies on the pneumococcal genome provided an initial overview of the genetic potential of
this pathogen. The pneumococcus is a highly versatile bacterium possessing a high rate of
uptake and recombination of exogenous DNA from neighboring bacteria. As such, a significant
diversity in the genome content among the different pneumococcal strains has been reported.
The capsular polysaccharide, an important pneumococcal virulence factor, is the best example
on the pneumococcal diversity. There are over 98 serotypes characterized to date presenting
differences in their capsule (cps) locus. Additional to the cps locus, the pneumococcus also
presents 13 genomic islets annotated as regions of diversity (RD) encoded in the auxiliary
genome. Remarkably, 8 of the pneumococcal RD studied so far have been associated with
virulence. Furthermore, the ongoing sequencing of over 4000 pneumococcal genomes have
shed light on the conservation level of well-known pneumococcal virulence factors.
Interestingly, important pneumococcal virulence determinants show variations in the gene and
protein sequence among the different strains. Prototypes are for example the pneumococcal
surface protein C (PspC) and pneumococcal adherence and virulence factor B (PavB).
Conversely, gene regulation in S. pneumoniae is carried out by highly conserved and genome-
wide distributed transcriptional factors. Overall, the pneumococci interplays with its
environment with 4 major regulatory systems: quorum sensing (QS), stand-alone
transcriptional regulators, small RNAs (sRNAs) and two-component regulatory systems (TCS).
Some of these systems are multifaceted and share more than one feature. Furthermore, there
is crosstalk among the different systems, requiring the activation of a signaling cascade to
function properly.
A comprehensive analysis of the distribution and conservation of pneumococcal
virulence factors and TCS was obtained in this study. The results are summarized as a
simplified variome in which 25 pneumococcal strains with a complete sequenced genome were
analyzed. Interestingly, the genes encoding the glycolytic protein enolase and the toxin
pneumolysin were the most conserved virulence determinants. Additionally, the high level of
conservation was confirmed for the pneumococcal TCS regulators, especially for WalKR,
CiaRH and TCS08.
The main focus of this study was on the regulatory functions of pneumococcal TCS.
With this in mind, an extensive and detailed systematic review of the 13 pneumococcal TCS
and its orphan RR was undertaken. For this purpose, every pneumococcal TCS was analyzed
for its reported functional and structural information along with its contribution to the main
pathophysiology of the pneumococci. In brief, S. pneumoniae can utilize its TCS for the
regulation of important cellular processes and the sensing of detectable signals in the
environment. Additionally, the role of TCS in pneumococcal processes and signal sensing can
be divided further. In the first place, pneumococcal TCS regulate competence and fratricide,
the production of bacteriocins and host-pathogen interaction processes, while the detectable
signals include cell-wall perturbations, environmental stress, and nutrients. As a conclusion
from this section, it is possible to analyze the pneumococcal TCS in a comprehensive manner.
There is a complex network among the different pneumococcal regulators and the TCS play
an important role. Moreover, these systems are highly conserved and essential for the proper
functioning of the pneumococcus as a pathogen.
Following up on pneumococcal TCS, this study focused especially on the TCS08.
Interestingly, the pneumococcal TCS08 has been previously associated with the regulation of the cellobiose metabolism. Furthermore, this system has also been reported to regulate the
expression of genes encoded in the RD4 (Pilus-1). Remarkably, the pneumococcal TCS08
was shown to be highly homologous to the SaeRS system of Staphylococcus aureus. Initially,
mutant strains lacking a single (Δrr08 or Δhk08) or both components (Δtcs08) of the TCS08
were generated in pneumococcal D39 and TIGR4 strains. Transcriptomics and functional
assays showed a downregulation of the PI-1 in the absence of the complete tcs08, while PavB
presented an upregulation in the Δhk08 knockout. Moreover, an important number of genes
coding for intermediary metabolism proteins were also found to be differentially expressed by
microarray analysis. As such, the TIGR4Δhk08 strain presented a downregulation for the
cellobiose operon (cel). In contrast, an upregulation was reported for the fatty acid biosynthesis
(fab) and arginine catabolism (arc) operons. Conversely, a decrease in gene expression was
seen in the TIGR4Δrr08 strain for the arc operon. Finally, in vivo murine pneumonia and sepsis
models highlighted an involvement of TCS08 in pneumococcal virulence. Remarkably, the
different TCS08 mutants presented a strain dependent effect on their virulence severity. The
TIGR4Δrr08, and all TCS08 mutants in D39 showed a decrease in virulence in the pneumonia
model, with no changes in sepsis. Conversely, the absence of HK08 in TIGR4 presented a
highly virulent phenotype in both pneumonia and sepsis models. To sum up, the pneumococcal
TCS08 influenced the expression of genes involved in fitness and colonization. Specifically,
those coding for the adhesins PavB and PI-1 and fitness proteins from the cel, arc and fab
operons. Remarkably, the highest changes in expression were observed in the strains lacking
the HK08. Additionally, TCS08 has a strain dependent impact on pneumococcal virulence as
showed by murine pneumonia and sepsis models when comparing the effects in D39 and
TIGR4.